Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.

Davies, G J; Tzivoni, D; Kobrin, I

Davies, G J; Tzivoni, D; Kobrin, I.

Affiliation

Davies GJ; Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.

Am J Cardiol ; 80(4B): 34C-39C, 1997 Aug 21.

Article in En | MEDLINE | ID: mdl-9286852

Subject(s)

Amlodipine/therapeutic use; Angina Pectoris/drug therapy; Benzimidazoles/therapeutic use; Calcium Channel Blockers/therapeutic use; Diltiazem/therapeutic use; Tetrahydronaphthalenes/therapeutic use; Adult; Aged; Aged, 80 and over; Amlodipine/pharmacology; Benzimidazoles/pharmacology; Calcium Channel Blockers/pharmacology; Chronic Disease; Diltiazem/pharmacology; Female; Hemodynamics/drug effects; Humans; Male; Mibefradil; Middle Aged; Nitroglycerin/administration & dosage; Tetrahydronaphthalenes/pharmacology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tetrahydronaphthalenes / Benzimidazoles / Calcium Channel Blockers / Diltiazem / Amlodipine / Angina Pectoris Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Cardiol Year: 1997 Document type: Article

Search on Google

XML

PubMed Links